Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication - PubMed (original) (raw)
. 2006 Nov 30;444(7119):638-42.
doi: 10.1038/nature05327.
Marzia Fumagalli, Angelo Cicalese, Sara Piccinin, Patrizia Gasparini, Chiara Luise, Catherine Schurra, Massimiliano Garre', Paolo Giovanni Nuciforo, Aaron Bensimon, Roberta Maestro, Pier Giuseppe Pelicci, Fabrizio d'Adda di Fagagna
Affiliations
- PMID: 17136094
- DOI: 10.1038/nature05327
Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication
Raffaella Di Micco et al. Nature. 2006.
Abstract
Early tumorigenesis is associated with the engagement of the DNA-damage checkpoint response (DDR). Cell proliferation and transformation induced by oncogene activation are restrained by cellular senescence. It is unclear whether DDR activation and oncogene-induced senescence (OIS) are causally linked. Here we show that senescence, triggered by the expression of an activated oncogene (H-RasV12) in normal human cells, is a consequence of the activation of a robust DDR. Experimental inactivation of DDR abrogates OIS and promotes cell transformation. DDR and OIS are established after a hyper-replicative phase occurring immediately after oncogene expression. Senescent cells arrest with partly replicated DNA and with DNA replication origins having fired multiple times. In vivo DNA labelling and molecular DNA combing reveal that oncogene activation leads to augmented numbers of active replicons and to alterations in DNA replication fork progression. We also show that oncogene expression does not trigger a DDR in the absence of DNA replication. Last, we show that oncogene activation is associated with DDR activation in a mouse model in vivo. We propose that OIS results from the enforcement of a DDR triggered by oncogene-induced DNA hyper-replication.
Similar articles
- Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints.
Bartkova J, Rezaei N, Liontos M, Karakaidos P, Kletsas D, Issaeva N, Vassiliou LV, Kolettas E, Niforou K, Zoumpourlis VC, Takaoka M, Nakagawa H, Tort F, Fugger K, Johansson F, Sehested M, Andersen CL, Dyrskjot L, Ørntoft T, Lukas J, Kittas C, Helleday T, Halazonetis TD, Bartek J, Gorgoulis VG. Bartkova J, et al. Nature. 2006 Nov 30;444(7119):633-7. doi: 10.1038/nature05268. Nature. 2006. PMID: 17136093 - Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis.
Sarkisian CJ, Keister BA, Stairs DB, Boxer RB, Moody SE, Chodosh LA. Sarkisian CJ, et al. Nat Cell Biol. 2007 May;9(5):493-505. doi: 10.1038/ncb1567. Epub 2007 Apr 22. Nat Cell Biol. 2007. PMID: 17450133 - DNA damage signalling guards against activated oncogenes and tumour progression.
Bartek J, Bartkova J, Lukas J. Bartek J, et al. Oncogene. 2007 Dec 10;26(56):7773-9. doi: 10.1038/sj.onc.1210881. Oncogene. 2007. PMID: 18066090 Review. - Oncogene-induced cellular senescence.
Chandeck C, Mooi WJ. Chandeck C, et al. Adv Anat Pathol. 2010 Jan;17(1):42-8. doi: 10.1097/PAP.0b013e3181c66f4e. Adv Anat Pathol. 2010. PMID: 20032638 Review. - Retinoblastoma loss modulates DNA damage response favoring tumor progression.
Seoane M, Iglesias P, Gonzalez T, Dominguez F, Fraga M, Aliste C, Forteza J, Costoya JA. Seoane M, et al. PLoS One. 2008;3(11):e3632. doi: 10.1371/journal.pone.0003632. Epub 2008 Nov 5. PLoS One. 2008. PMID: 18985151 Free PMC article.
Cited by
- Loss of myosin light chain kinase induces the cellular senescence associated secretory phenotype to promote breast epithelial cell migration.
Kim D, Cooper JA, Helfman DM. Kim D, et al. Sci Rep. 2024 Oct 28;14(1):25786. doi: 10.1038/s41598-024-76868-y. Sci Rep. 2024. PMID: 39468273 Free PMC article. - Exploiting oncogene-induced replicative stress for the selective killing of Myc-driven tumors.
Murga M, Campaner S, Lopez-Contreras AJ, Toledo LI, Soria R, Montaña MF, Artista L, Schleker T, Guerra C, Garcia E, Barbacid M, Hidalgo M, Amati B, Fernandez-Capetillo O. Murga M, et al. Nat Struct Mol Biol. 2011 Nov 27;18(12):1331-1335. doi: 10.1038/nsmb.2189. Nat Struct Mol Biol. 2011. PMID: 22120667 Free PMC article. - A high-content cellular senescence screen identifies candidate tumor suppressors, including EPHA3.
Lahtela J, Corson LB, Hemmes A, Brauer MJ, Koopal S, Lee J, Hunsaker TL, Jackson PK, Verschuren EW. Lahtela J, et al. Cell Cycle. 2013 Feb 15;12(4):625-34. doi: 10.4161/cc.23515. Epub 2013 Jan 16. Cell Cycle. 2013. PMID: 23324396 Free PMC article. - Therapy-Induced Cellular Senescence: Potentiating Tumor Elimination or Driving Cancer Resistance and Recurrence?
Liu Y, Lomeli I, Kron SJ. Liu Y, et al. Cells. 2024 Jul 30;13(15):1281. doi: 10.3390/cells13151281. Cells. 2024. PMID: 39120312 Free PMC article. Review. - TICRR Overexpression Enhances Disease Aggressiveness and Immune Infiltration of Cutaneous Melanoma.
Chen C, Zou Y, Zheng X, Hu T, Ni J, Kan D, Yin Z, Ye L, Liu B. Chen C, et al. Pharmgenomics Pers Med. 2024 Sep 3;17:423-435. doi: 10.2147/PGPM.S469972. eCollection 2024. Pharmgenomics Pers Med. 2024. PMID: 39246575 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources